No health risks, including no carcinogenicity, were found for the GM maize tested, reaffirming the conclusions of previous risk assessments.
The cultivation of genetically modified crops has long been a contentious issue in the European Union. Now a group of biotech specialists and legal experts propose a mechanism to take the political edge out of the authorization process.
The Dutch Commission on Genetic Modification assessed the value and possible pitfalls of stakeholder participation based on experiences in and results of the GRACE project.
MON810 maize at a level of up to 33 % in the diet did not induce adverse effects in male and female Wistar Han RCC rats after a chronic exposure.
Detailed response from the GRACE team to comments of the Austrian Agency for Health and Food Safety (AGES) on the final project report of GRACE and the following response from AGES.
18th-20th of April 2016, Berlin, Germany
Conclusions and recommendations on animal feeding trials and alternative approaches and on the use of systematic reviews and evidence maps for GMO impact assessment.
Scientific value of feeding trials and alternative approaches for GMO safety assessment and improved methods for risk/benefit assessments.
The recent GRACE paper concludes that systematic reviews can provide robust answers to scientific questions compatible with the demands of GMO risk assessment and management.
GRACE involves stakeholders in research planning and drawing of conclusions. Read here for more information.
New Stakeholder Consultation Reports:
Consultation on Good Review Practice in GMO Impact Assessment
The database CADIMA (Central Access Database for Impact Assessment of Crop Genetic Improvement Technologies) contains quality assessed studies and conclusions on the health effects, socio-economic consequences and environmental impacts of GM plants as well as raw data of animal feeding studies and alternative in vitro approaches.